{"id":127938,"date":"2026-01-07T06:56:08","date_gmt":"2026-01-07T06:56:08","guid":{"rendered":"https:\/\/www.europesays.com\/se\/127938\/"},"modified":"2026-01-07T06:56:08","modified_gmt":"2026-01-07T06:56:08","slug":"facebookannons-for-melatonin-falls-av-ign","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/se\/127938\/","title":{"rendered":"Facebookannons f\u00f6r melatonin f\u00e4lls av IGN"},"content":{"rendered":"<p>L\u00e4kemedelsf\u00f6retaget Unimedic pharma AB f\u00f6r bakl\u00e4xa av Informationsgranskningsn\u00e4mnden, IGN, f\u00f6r en Facebookannons f\u00f6r melatonin mot jetlag. I Facebooktexten framh\u00e5ller f\u00f6retaget produktens f\u00f6rdelar men n\u00e4mner inte att det handlar om ett l\u00e4kemedel.\u00a0IGN <a href=\"https:\/\/www.lif.se\/etik\/ign-och-nbl\/detaljer\/?id=3728\" rel=\"nofollow noopener\" target=\"_blank\">konstaterar<\/a>\u00a0d\u00e4rf\u00f6r att annonsen inte uppfyller det etiska regelverkets krav p\u00e5 tydlighet i l\u00e4kemedelsreklam.<\/p>\n<p>Facebookannons f\u00f6r melatonin<\/p>\n<p>Reklamen g\u00e4ller s\u00f6mnmedlet Melatonin Unimedic l\u00f6sning som \u00e4r godk\u00e4nt f\u00f6r korttidsbehandling av jetlag hos vuxna som flyger \u00f6ver flera tidszoner. L\u00e4kemedlet \u00e4r \u00e4ven godk\u00e4nt f\u00f6r behandling av s\u00f6mnproblem hos barn i \u00e5ldrarna 6\u201317 \u00e5r som har ADHD och d\u00e4r s\u00f6mnhygien\u00e5tg\u00e4rder inte har hj\u00e4lpt.<\/p>\n<p><strong>\u201dJetlag p\u00e5 resan?<\/strong> Nu finns l\u00f6sningen \u2013 receptfritt! S\u00e4g hej till Sveriges f\u00f6rsta receptfria orala l\u00f6sning av melatonin\u201d, skriver Unimedic i annonsen. Det st\u00e5r ocks\u00e5 att produkten finns p\u00e5 apotek och att man ska l\u00e4sa bipacksedeln innan man anv\u00e4nder det. Men det r\u00e4cker inte, menar IGN, som h\u00e4nvisar till ett v\u00e4gledande utl\u00e5tande fr\u00e5n \u00f6verinstansen NBL, N\u00e4mnden f\u00f6r bed\u00f6mning av l\u00e4kemedelsinformation:<\/p>\n<p>\u201dPraxis har visat att det i praktiken \u00e4r sv\u00e5rt att f\u00e5 det att framg\u00e5 att det \u00e4r ett l\u00e4kemedel utan att uttryckligen ange detta.\u201d<\/p>\n<p>Icke medlen \u2013 slipper straffavgift<\/p>\n<p>I sitt svarom\u00e5l accepterar Unimedic kritiken och redog\u00f6r f\u00f6r olika \u00e5tg\u00e4rder som ska f\u00f6rhindra en upprepning. Bland annat har f\u00f6retaget g\u00e5tt igenom sina annonsmallar f\u00f6r att se till att ordet \u201dl\u00e4kemedel\u201d alltid finns med. Dessutom har man sk\u00e4rpt sin godk\u00e4nnandeprocess inf\u00f6r publicering i sociala medier.<\/p>\n<p><strong>IGN:s f\u00e4llning skulle<\/strong> ha lett till en straffavgift p\u00e5 110 000 kronor. Men eftersom Unimedic inte \u00e4r med i L\u00e4kemedelsindustrif\u00f6reningen Lif eller n\u00e5gon av de andra tv\u00e5 branschorganisationerna bakom det etiska regelverket s\u00e5 kan IGN inte kr\u00e4va f\u00f6retaget p\u00e5 n\u00e5gon avgift.<\/p>\n","protected":false},"excerpt":{"rendered":"L\u00e4kemedelsf\u00f6retaget Unimedic pharma AB f\u00f6r bakl\u00e4xa av Informationsgranskningsn\u00e4mnden, IGN, f\u00f6r en Facebookannons f\u00f6r melatonin mot jetlag. I Facebooktexten&hellip;\n","protected":false},"author":2,"featured_media":127939,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[12],"tags":[22,23,26,27,17,21,13225,13226,24,25,28,29,15,16,18,34,31,33,32,30,19,20],"class_list":["post-127938","post","type-post","status-publish","format-standard","has-post-thumbnail","category-sverige","tag-breaking-news","tag-breakingnews","tag-featured-news","tag-featurednews","tag-headlines","tag-huvudnyheter","tag-ign","tag-informationsgranskningsnamnden","tag-latest-news","tag-latestnews","tag-main-news","tag-mainnews","tag-news","tag-nyheter","tag-rubriker","tag-se","tag-svenska","tag-sverige","tag-sweden","tag-swedish","tag-top-stories","tag-topstories"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@se\/115852514581588288","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/127938","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/comments?post=127938"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/127938\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media\/127939"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media?parent=127938"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/categories?post=127938"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/tags?post=127938"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}